Displaying 10 out of 5 results

  1. The GSK logo is seen on top of GSK Asia House in Singapore

    GSK's Trelegy Ellipta meets key goal in late-stage asthma study

    British drugmaker GlaxoSmithKline Plc said on Thursday that its respiratory drug Trelegy Ellipta met the main goal of a late-stage asthma study, ...
  2. New Content Item

    Mylan and Theravance Biopharma's COPD treatment gets FDA approval

  3. lung diseases

    Two lung diseases killed 3.6 million in 2015: Study